- DNA
technology and is
marketed as a
protein therapeutic and
branded as
Proleukin. It has been
approved by the Food and Drug
Administration (FDA) with a...
- been sold, that IL-2 was approved. It is now
distributed under the name
Proleukin. The
company also had a
broad effort to
research and
develop techniques...
- for
research and development. In 1992, the company's
first product,
Proleukin, was
approved in
United States for the
treatment of
metastatic melanoma;...
- w****s.
Cytokine therapies used for
melanoma include IFN-a and IL-2. IL-2 (
Proleukin) was the
first new
therapy approved (1990 EU, 1992 US) for the treatment...
- BCG (TheraCys, TICE) (1990) G-CSF (1991) GM-CSF (1991)
Interleukin 2 (
Proleukin) (1992) The NCI is
divided into
several divisions and centers. Center...
-
Prohance proheptazine (INN)
Proketazine Prokine (Immunex Corp)
Proklar Proleukin (Chiron)
proligestone (INN)
proline (INN)
prolintane (INN)
Prolixin Proloid...
- 1990-1991 -
EuroCetus facility licensed for
production and
release of
ProLeukin (IL-2) for
Europe and rest of world,
except US and ****an. 1992 – Chiron...
-
first biotechnology companies.
Produced pharmaceuticals Betaseron and
Proleukin. They also
developed the PCR process,
which won a
Nobel Prize for its...
- (Votrient),
sorafenib (Nexavar),
temsirolimus (Torisel), interleukin-2 (
Proleukin),
everolimus (Afinitor),
bevacizumab (Avastin), and aldesleukin. Renal...
